Monoclonal Antibody IV Therapy

We no longer can provide Monoclonal Antibody Infusion due to the FDA withdrawal of the approval.

In nonhospitalized patients with mild to moderate COVID-19 who are at high risk of progressing to severe disease, Remdesivir should be started within 7 days of symptom onset and administered for 3 days.

For more information, please contact our IV Therapy Department at 843.758.0044

Corporate Office:

201 South Fifth Street
Hartsville, SC 29550
843-857-0111

This health center is a Health Center Program grantee under 42 U.S.C. 254b, and a deemed Public Health Service employee under 42 U.S.C. 233(g)-(n). This health center receives HHS funding and has Federal PHS deemed status with respect to certain health or health-related claims, including medical malpractice claims, for itself and its covered individuals. Privacy Policy

Monoclonal Antibody IV Therapy

Error Message